Recurrent Glioblastoma Multiforme research hub

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

This study is testing a new drug, AZD1390, alongside standard radiation for brain cancer. It's the first time AZD1390 has been given to patients. The main goal is to check its safety and how the body handles it, especially when combined with different types of radiation.